Johnson & Johnson (JNJ)
NYSE: JNJ · IEX Real-Time Price · USD
146.82
-1.71 (-1.15%)
At close: Apr 25, 2024, 4:00 PM
146.48
-0.34 (-0.23%)
After-hours: Apr 25, 2024, 7:59 PM EDT
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $353.80 billion as of April 25, 2024. Its market cap has decreased by -15.62% in one year.
Market Cap
353.80B
Enterprise Value
360.21B
1-Year Change
-15.62%
Ranking
Category
Stock Price
$146.82
Market Cap Chart
Since May 14, 2001, Johnson & Johnson's market cap has increased from $136.61B to $353.80B, an increase of 158.99%. That is a compound annual growth rate of 4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2024 | 357.77B | -0.69% |
| Apr 23, 2024 | 360.26B | 0.30% |
| Apr 22, 2024 | 359.20B | 0.82% |
| Apr 19, 2024 | 356.28B | 1.49% |
| Apr 18, 2024 | 351.05B | 0.67% |
| Apr 17, 2024 | 348.72B | 0.22% |
| Apr 16, 2024 | 347.95B | -2.13% |
| Apr 15, 2024 | 355.51B | 0.05% |
| Apr 12, 2024 | 355.34B | -0.85% |
| Apr 11, 2024 | 358.40B | -0.94% |
| Apr 10, 2024 | 361.80B | -1.37% |
| Apr 9, 2024 | 366.83B | 0.46% |
| Apr 8, 2024 | 365.15B | -0.52% |
| Apr 5, 2024 | 367.07B | -0.07% |
| Apr 4, 2024 | 367.34B | -1.14% |
| Apr 3, 2024 | 371.58B | -2.20% |
| Apr 2, 2024 | 379.93B | -0.03% |
| Apr 1, 2024 | 380.06B | -0.26% |
| Mar 28, 2024 | 381.04B | 0.15% |
| Mar 27, 2024 | 380.49B | 1.41% |
| Mar 26, 2024 | 375.21B | 0.35% |
| Mar 25, 2024 | 373.89B | -0.01% |
| Mar 22, 2024 | 373.91B | -0.33% |
| Mar 21, 2024 | 375.17B | -0.01% |
| Mar 20, 2024 | 375.19B | -0.29% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 695.32B |
| Novo Nordisk | 564.00B |
| UnitedHealth Group | 452.88B |
| Merck & Co. | 321.49B |
| AbbVie | 297.27B |
| AstraZeneca | 217.39B |
| Thermo Fisher | 209.32B |
| Novartis AG | 186.10B |